8 Hepatitis B Vaccine | Adverse Effects of Vaccines: Evidence and Causality |The National Academies Press
![Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/11f54e1c-2994-433c-b95d-0bb9e6443896/fx1_lrg.jpg)
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development
![Hepatitis A virus knowledge and immunization attitudes and practices in the United Arab Emirates community | Scientific Reports Hepatitis A virus knowledge and immunization attitudes and practices in the United Arab Emirates community | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80089-4/MediaObjects/41598_2020_80089_Fig1_HTML.png)
Hepatitis A virus knowledge and immunization attitudes and practices in the United Arab Emirates community | Scientific Reports
![Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971220300503-gr1.jpg)
Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect
![Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/6bfe121f-8f79-4f98-a30f-d5d956b5a71f/gr1_lrg.gif)